ESR2 and breast carcinoma: The two ERβ species detected by western blot at approximately 59 and 54 kDa are compatible with ERβ1 (59.2 kDa) and ERβ2 (55.5 kDa), and their negative relationship with ERα expression is in keeping with the described roles of these isoforms in the breast cancer literature [41].